1-[2-(2,4-DIMETHYLPHENYLSULFANYL)-PHENYL]PIPERAZINE AS A COMPOUND With COMBINED SEROTONIN REUPTAKE, 5-HT3 AND 5-HT1A ACTIVITY FOR THE TREATMENT OF COGNITIVE IMPAIRMENT

1-[2-(2,4-dimethylphenylsulphanyl)phenyl]piperazine exhibits potent activity on SERT, 5-HT3 and 5-HT1A and may as such be useful for the treatment of cognitive impairment, especially in depressed patients.

Saved in:
Bibliographic Details
Main Authors FALDT ANDRÉ, MØRK ARNE, MOORE NICHOLAS, ROCK MICHAEL HAROLD, HOLM RENÉ, BANG-ANDERSEN BENNY, RINGGARD LONE MUNCH, LOPEZ DE DIEGO HEIDI, JØRGENSEN MORTEN, STENSBØL TINE BRYAN, MEALY MICHAEL J, BRODERSEN JØRGEN
Format Patent
LanguageEnglish
Published 24.03.2016
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

Abstract 1-[2-(2,4-dimethylphenylsulphanyl)phenyl]piperazine exhibits potent activity on SERT, 5-HT3 and 5-HT1A and may as such be useful for the treatment of cognitive impairment, especially in depressed patients.
AbstractList 1-[2-(2,4-dimethylphenylsulphanyl)phenyl]piperazine exhibits potent activity on SERT, 5-HT3 and 5-HT1A and may as such be useful for the treatment of cognitive impairment, especially in depressed patients.
Author LOPEZ DE DIEGO HEIDI
FALDT ANDRÉ
MEALY MICHAEL J
HOLM RENÉ
STENSBØL TINE BRYAN
RINGGARD LONE MUNCH
BRODERSEN JØRGEN
BANG-ANDERSEN BENNY
MØRK ARNE
ROCK MICHAEL HAROLD
JØRGENSEN MORTEN
MOORE NICHOLAS
Author_xml – fullname: FALDT ANDRÉ
– fullname: MØRK ARNE
– fullname: MOORE NICHOLAS
– fullname: ROCK MICHAEL HAROLD
– fullname: HOLM RENÉ
– fullname: BANG-ANDERSEN BENNY
– fullname: RINGGARD LONE MUNCH
– fullname: LOPEZ DE DIEGO HEIDI
– fullname: JØRGENSEN MORTEN
– fullname: STENSBØL TINE BRYAN
– fullname: MEALY MICHAEL J
– fullname: BRODERSEN JØRGEN
BookMark eNqNjNtKw0AQhnOhF_XwDgPeKHShSVqxl2MycQeT3WUzUWKRUmRFQdJC-059zW7QB_DqP338F8nZsB3CJDmmapWp22w6VyU3JLqvnSbT121XVxj1Tv3md8eOPL6xIcAWEArbONuZEl6_D19jeoxTCS15K9awAU-dE3ymKSyUlhwwsqNLEbAQfmHpobIeRBOIJ5SGjICt4teT4QgQcOOQ_dhfJeefm599uP7Ty-SmIim0CrvtOux3m48whMO6a7NZej97yPPFEtP8f9QJNSdJdg
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US2016083359A1
GroupedDBID EVB
ID FETCH-epo_espacenet_US2016083359A13
IEDL.DBID EVB
IngestDate Fri Jul 19 13:04:46 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US2016083359A13
Notes Application Number: US201514948775
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160324&DB=EPODOC&CC=US&NR=2016083359A1
ParticipantIDs epo_espacenet_US2016083359A1
PublicationCentury 2000
PublicationDate 20160324
PublicationDateYYYYMMDD 2016-03-24
PublicationDate_xml – month: 03
  year: 2016
  text: 20160324
  day: 24
PublicationDecade 2010
PublicationYear 2016
RelatedCompanies H. LUNDBECK A/S
RelatedCompanies_xml – name: H. LUNDBECK A/S
Score 3.023446
Snippet 1-[2-(2,4-dimethylphenylsulphanyl)phenyl]piperazine exhibits potent activity on SERT, 5-HT3 and 5-HT1A and may as such be useful for the treatment of cognitive...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Title 1-[2-(2,4-DIMETHYLPHENYLSULFANYL)-PHENYL]PIPERAZINE AS A COMPOUND With COMBINED SEROTONIN REUPTAKE, 5-HT3 AND 5-HT1A ACTIVITY FOR THE TREATMENT OF COGNITIVE IMPAIRMENT
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160324&DB=EPODOC&locale=&CC=US&NR=2016083359A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1fT8IwEG8IGvVNUeMfNE00RBMa2RgwHogpW-emsC1bh6AxhLERSQwQmfEj-TW9DlCeeGqv11zSNtfetb_rIXStysogKldjUlOikChVSSLhIAa9Kg_U0lANh7VRivK1q2agPHYr3Qz6WMXCpP-EfqefI4JGDUHfk3S_nv1fYukptnJ-F46haXpv8IZeWHrHImeyrBT0ZoO5ju5oBU1rBH7B9hY8EWBUp-ArbYEhXRMAMNZpiriU2fqhYuyjbRfkTZIDlIknObSrrXKv5dBOe_nkDdWl9s0P0Y9EXmVyIxcVolttxs1eyzWZ3Wv5QcugUN6SBf3mWi7z6ItlM0x9TLHmtF0nsHX8PE7eBdUElo595jncsS0beyxwOX1iRVwhJi9jCn1FTaJYwEw6Fu9h8BcxNxnmHqNc5ADAjgGyHmwLOjBstV1qeaL9CF0ZjGsmgRH3_ya4H_jr01M-RtnJdBKfIBxKUQ0syFIYqaoSl6qDkXgFjOoqGFWlSiU8RflNks42s8_RniAFoktW8iibfH7FF3DEJ-FlujK_UlydQw
link.rule.ids 230,309,783,888,25578,76884
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1dS8MwMAwV9U2n4rcBZSgYXLtuqw9Dsja10TYtbapOkbGuFQWZohV_kn_TS7epTz4luQsHuXDJXXIfCB2YujHIGq2ctI0sJUZL00g6yEGuGgOzPjTTYfuh9PIVLTcxLm6aNxX0PI2FKfOEfpbJEUGihiDvRXlev_4-Ytmlb-X7SfoEoJczR3bs2sQ6VjWTdaNmdzssDOzAqllWJ4lrIhrjVIDRKQVbaRaUbFNl2mdXXRWX8vr3UnGW0FwI9EbFMqrkoypasKa116po3p98eUN3In3vK-hLI3c6OdSPDWJzn0m354UuEz0vTjyHQntExuP7kIcsordcMExjTLEV-GGQCBtfPxWPatQFlI1jFgUyEFzgiCWhpJfsGDeJKxuYwlzV0yhWbiZXXPYw2ItYugzLiFGpagDgwAFa54LDBIa5H1IeKfgq2neYtFwCK-7_MLifxH_Z01hDM6OXUb6OcKplbdAg62kG7MrrrcGD-gXMTk1QqurNZrqBtv-jtPk_eg8tuNL3-h4Xl1toUaGUd5dubKOZ4u0j34Hrvkh3y136BtzDoDM
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=1-%5B2-%282%2C4-DIMETHYLPHENYLSULFANYL%29-PHENYL%5DPIPERAZINE+AS+A+COMPOUND+With+COMBINED+SEROTONIN+REUPTAKE%2C+5-HT3+AND+5-HT1A+ACTIVITY+FOR+THE+TREATMENT+OF+COGNITIVE+IMPAIRMENT&rft.inventor=FALDT+ANDR%C3%89&rft.inventor=M%C3%98RK+ARNE&rft.inventor=MOORE+NICHOLAS&rft.inventor=ROCK+MICHAEL+HAROLD&rft.inventor=HOLM+REN%C3%89&rft.inventor=BANG-ANDERSEN+BENNY&rft.inventor=RINGGARD+LONE+MUNCH&rft.inventor=LOPEZ+DE+DIEGO+HEIDI&rft.inventor=J%C3%98RGENSEN+MORTEN&rft.inventor=STENSB%C3%98L+TINE+BRYAN&rft.inventor=MEALY+MICHAEL+J&rft.inventor=BRODERSEN+J%C3%98RGEN&rft.date=2016-03-24&rft.externalDBID=A1&rft.externalDocID=US2016083359A1